Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders

Sean B Johnston1, Ronald T Raines

  • 1Department of Biochemistry and ‡Department of Chemistry, University of Wisconsin-Madison , Madison, Wisconsin 53706, United States.

Biochemistry
|February 4, 2015
PubMed

Insights

The enzyme phosphatase and tensin homolog (PTEN) is crucial for cell regulation but is fragile. Cancer and autism-linked PTEN variants show reduced stability or activity, with autism variants being more active.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Metabolism

Background:

  • Phosphoinositides, like PIP3, are key membrane regulators in mammalian cells.
  • The enzyme PTEN dephosphorylates PIP3 and is frequently impaired in tumors and linked to developmental disorders.
  • PTEN's role in cellular metabolism and disease necessitates understanding its stability and function.

Purpose of the Study:

  • To investigate the conformational stability and catalytic activity of human PTEN.
  • To compare PTEN variants associated with cancer and autism spectrum disorders.
  • To characterize the properties of the PTEN-L isoform.

Main Methods:

  • Analysis of human PTEN conformational stability under physiological conditions.
  • Assessment of catalytic activity for wild-type and variant PTEN.
  • Comparison of PTEN and PTEN-L properties.

Main Results:

  • Human PTEN exists near its unfolding point under physiological conditions, indicating fragility.
  • PTEN variants linked to cancer and autism exhibit compromised conformational stability and/or catalytic activity.
  • PTEN variants associated solely with autism display higher catalytic activity than cancer-linked variants.
  • The secreted PTEN-L isoform demonstrates superior conformational stability compared to wild-type PTEN.

Conclusions:

  • PTEN is a fragile enzyme critical for cellular metabolism.
  • Impaired PTEN stability or activity contributes to cancer and developmental disorders.
  • PTEN-L represents a stable reservoir of PTEN's catalytic function.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
10.0K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K